Cas 1028801-48-0,methyl 1-((benzyloxycarbonyl)(tert-butoxycarbonyl)amino)-2-(difluoromethyl)cyclopropanecarboxylate

1028801-48-0

Post Buying Request

Basic information

Product Name: methyl 1-((benzyloxycarbonyl)(tert-butoxycarbonyl)amino)-2-(difluoromethyl)cyclopropanecarboxylate
Synonyms: methyl 1-((benzyloxycarbonyl)(tert-butoxycarbonyl)amino)-2-(difluoromethyl)cyclopropanecarboxylate
CAS NO:1028801-48-0
Molecular Formula:
Molecular Weight: 399.392
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: methyl 1-((benzyloxycarbonyl)(tert-butoxycarbonyl)amino)-2-(difluoromethyl)cyclopropanecarboxylate(CAS DataBase Reference)
NIST Chemistry Reference: methyl 1-((benzyloxycarbonyl)(tert-butoxycarbonyl)amino)-2-(difluoromethyl)cyclopropanecarboxylate(1028801-48-0)
EPA Substance Registry System: methyl 1-((benzyloxycarbonyl)(tert-butoxycarbonyl)amino)-2-(difluoromethyl)cyclopropanecarboxylate(1028801-48-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1028801-48-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1028801-48-0 Suppliers

Recommended suppliers

1028801-48-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1028801-48-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,8,8,0 and 1 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1028801-48:
(9*1)+(8*0)+(7*2)+(6*8)+(5*8)+(4*0)+(3*1)+(2*4)+(1*8)=130
130 % 10 = 0
So 1028801-48-0 is a valid CAS Registry Number.

1028801-48-0Upstream product

1028801-48-0Downstream Products

1028801-48-0Relevant academic research and scientific papers

AMIDE DERIVATIVES USEFUL IN THE TREATMENT OF HBV INFECTION OR HBV-INDUCED DISEASES

-

Page/Page column 60-61, (2020/09/08)

The application relates to amide derivatives, processes for their preparation, pharmaceutical compositions, and their uses, more particularly their uses in treating chronic hepatitis B virus (HBV) infection.

HEPATITIS C VIRUS INHIBITORS

-

, (2009/12/02)

Hepatitis C virus inhibitors having the general formula are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1028801-48-0